One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Centers for Disease Control and Prevention. Provisional drug overdose death counts, 2021. Accessed November 20, 2021. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
- Vital signs: trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017.MMWR Morb Mortal Wkly Rep. 2018; : 279-285
- Emergency department-initiated interventions for patients with opioid use disorder: a systematic review.Acad Emerg Med. 2020; 27: 1173-1182
- Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone?.Can Fam Physician. 2017; 63: 200-205
- Emergency department treatment of opioid addiction: an opportunity to lead.Acad Emerg Med. 2018; 25: 601-604
- Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.JAMA. 2015; 313: 1636-1644
- Cost-effectiveness of emergency department-initiated treatment for opioid dependence.Addiction. 2017; 112: 2002-2010
- Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.Ann Intern Med. 2018; 169: 137-145
- American College of Emergency Physicians.https://www.acep.org/administration/quality/equal/e-qual-opioid-initiative/#sm.001836nzfraier110zc172wo1cqzn
- State and Local Policy Levers for Increasing Treatment and Recovery Capacity to Address the Opioid Epidemic: Final Report.US Department of Health and Human Services. 2017;https://www.acep.org/administration/quality/equal/emergency-quality-network-e-qual/e-qual-opioid-initiative/Date accessed: November 20, 2021
- Barriers and facilitators to the use of medications for opioid use disorder: a rapid review.J Gen Intern Med. 2020; 35: 954-963
- Barriers and facilitators for emergency department initiation of buprenorphine: a physician survey.Am J Emerg Med. 2019; 37 (1787–1709)
- Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine.JAMA Netw Open. 2020; 3e204561
Federal Register. Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder. US Department of Health and Human Services; 2021. Document Number 2021–08961. Accessed November 20, 2021. https://www.govinfo.gov/content/pkg/FR-2021-04-28/pdf/2021-08961.pdf
- Monthly patient volumes of buprenorphine-waivered clinicians in the US.JAMA Netw Open. 2020; 3e2014045
- Physician attitudes on buprenorphine induction in the emergency department: results from a multistate survey.Clin Toxicol (Phila). 2021; 59: 279-285
- Providing incentive for emergency physician X-waiver training: an evaluation of program success and postintervention buprenorphine prescribing.Ann Emerg Med. 2020; 76: 206-214
- Evaluating the public health impact of health promotion interventions: the RE-AIM framework.Am J Public Health. 1999; 89: 1322-1327
- SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.BMJ Qual Saf. 2016; 25: 986-992
- 2016 Overdoses From Opioids in Philadelphia. Philadelphia Department of Public Health.http://www.phila.gov/health/pdfs/chart%20v2e7.pdfDate accessed: November 20, 2021
- DSM-5 Diagnoses and New ICD-10-CM Codes As Ordered in the ICD-10-CM Classification. American Psychiatric Association.https://www.psychiatry.org/psychiatrists/practice/dsm/updates-to-dsm-5/coding-updates/as-ordered-in-the-icd-10-cm-classificationDate accessed: May 1, 2021
- Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.Med Care. 2012; 50: 217-226
- Implementation strategies: recommendations for specifying and reporting.Implement Sci. 2013; 8: 139
- A behavior model for persuasive design. Paper presented at: Proceedings of the 4th International Conference on Persuasive Technology.California, USA, ClaremontApril 26-29, 2009 (April 26-29, 2009.)
- Integrating implementation and user-centred design strategies to enhance the impact of health services: protocol from a concept mapping study.Health Res Policy Syst. 2019; 17: 1-11
- A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project.Implement Sci. 2015; 10: 1-14
- Insourcing health care innovation.N Engl J Med. 2014; 370: 1775
- Peer recovery support for individuals with substance use disorders: assessing the evidence.Psychiatr Serv. 2014; 65: 853-861
- Addressing substance use disorder in primary care: the role, integration, and impact of recovery coaches.Subst Abus. 2018; 39: 307-314
- Implementing peer recovery services for overdose prevention in Rhode Island: an examination of two outreach-based approaches.Addict Behav. 2019; 89: 85-91
- Identifying opioid use disorder in the emergency department: multi-system electronic health record-based computable phenotype derivation and validation study.JMIR Med Inform. 2019; 7e15794
- Making workplace civility go viral.NEJM Catalyst. 2020; 1
- A quality framework for emergency department treatment of opioid use disorder.Ann Emerg Med. 2019; 73: 237-247
US Electronic Code of Federal Regulations. Medication Assisted Treatment for Opioid Use Disorders. 2016. 42 CFR Part 8. Accessed 20 November, 2021. https://www.ecfr.gov/#se42.1.8_112
- R: a language and environment for statistical computing [computer program]. Austria, Vienna2018
- Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study.J Gen Intern Med. 2021; 36: 1264-1270
- A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers.Am J Emerg Med. 2020; 38: 1286-1290
- Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program.Am J Emerg Med. 2020; 38: 300-304
- Treating opioid withdrawal with buprenorphine in a community hospital emergency department: an outreach program.Ann Emerg Med. 2020; 75: 49-56
- Implementation of a medication for addiction treatment (MAT) and linkage program by leveraging community partnerships and medical toxicology expertise.J Med Toxicol. 2021; 17: 176-184
- Interrupted time series of user-centered clinical decision support implementation for emergency department-initiated buprenorphine for opioid use disorder.Acad Emerg Med. 2020; 27: 753-763
- Emergency department screening and interventions for substance use disorders.Addict Sci Clin Pract. 2018; 13: 18
- Emergency department-based peer support for opioid use disorder: emergent functions and forms.J Subst Abuse Treat. 2020; 108: 82-87
- Harnessing the power of default options to improve health care.N Engl J Med. 2007; 357: 1340-1344
- Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments.J Gen Intern Med. 2018; 33: 409-411
- Default options in advance directives influence how patients set goals for end-of-life care.Health Aff (Millwood). 2013; 32: 408-417
- Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose.JAMA Netw Open. 2019; 2e193209
- Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.Am J Emerg Med. 2021; 47: 154-157
- Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial.JAMA. 2013; 309: 2345-2352
- Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial.JAMA. 2016; 315: 562-570
- Assessing the effectiveness of peer comparisons as a way to improve health care quality.Health Aff (Millwood). 2020; 39: 852-861
- Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X Waiver.JAMA Psychiatry. 2019; 76: 229-230
The Mainstreaming Addiction Treatment (MAT) Act. In. 2021-2022 ed2021.
Publication stageIn Press Corrected Proof
Please see page XX for the Editor’s Capsule Summary of this article.
Supervising editor: Donald M. Yealy, MD. Specific detailed information about possible conflict of interest for individual editors is available at https://www.annemergmed.com/editors.
Author contributions: ML and MKD were responsible for the study concept and design. ML, CS, and MKD were responsible for acquisition of the data. ML, RAX, NM, and MKD analyzed and interpreted the data. ML and MKD drafted the manuscript, and JP, NO, DH, RR, JD, RM, UK, and ZFM critically revised the manuscript for important intellectual content. RAX and NM were responsible for statistical expertise. MKD and JD were responsible for acquisition of funding. ML takes responsibility for the paper as a whole.
All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). This work was supported by the Penn Injury Science Center (CDC 19R49CE003083), Penn Medicine Center for Health Care Innovation Accelerator Program, and SAMHSA (H79TI081596-01). Dr. Delgado was also supported by the National Institute of Child Health and Human Development (grant K23HD090272001) and by a philanthropic grant from the Abramson Family Foundation.